SkinBioTherapeutics PLC Director/PDMR Shareholding (4957S)
March 09 2023 - 11:18AM
UK Regulatory
TIDMSBTX
RNS Number : 4957S
SkinBioTherapeutics PLC
09 March 2023
9 March 2023
SkinBioTherapeutics plc
("SBTX" or the "Company")
Director Bed & ISA Dealings
SkinBioTherapeutics plc (AIM: SBTX), the life science company
focused on skin health , announces that it received notification on
9 March 2023 that Stuart Ashman , CEO and PDMR , sold 89,472
ordinary shares of 1p each in the Company ("Ordinary Shares") and
repurchased 86,387 Ordinary Shares into Mr Ashman's ISA account.
Following this transaction Stuart Ashman's beneficial interest in
the Company shares has decreased from 281,250 to 278,165 ordinary
shares, with the variance owing to commissions and costs of the
transactions .
Details of PDMR transaction
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Stuart Ashman
------------------------------------ -------------------------------------------------
Reason for the notification
2
---------------------------------------------------------------------------------------
a) Position/status PDMR (CEO)
------------------------------------ -------------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------ -------------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------------------
a) Name SkinBioTherapeutics plc
------------------------------------ -------------------------------------------------
b) LEI 213800YMQOCB23FX6I06
------------------------------------ -------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
4 each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been conducted
---------------------------------------------------------------------------------------
a) Description of the financial Ordinary Shares in SkinBioTherapeutics plc
instrument, type of
instrument
Identification code GB00BF33H870
b) Nature of the transaction Sale and purchase of ordinary shares
------------------------------------ -------------------------------------------------
c) Price(s) and volume(s)
------------------------------ --------------
Price(s) Volume(s)
------------------------------ --------------
Sale at 22.75 p 89,472
------------------------------------------------------------------------ --------------
Purchase at 22.75
p 86,387
------------------------------------------------------------------------ --------------
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transactions 6 March 2023
------------------------------------ -------------------------------------------------
f) Place of the transaction N/A
------------------------------------ -------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHQKLFBXXLEBBX
(END) Dow Jones Newswires
March 09, 2023 12:18 ET (17:18 GMT)
Skinbiotherapeutics (LSE:SBTX)
Historical Stock Chart
From Apr 2024 to May 2024
Skinbiotherapeutics (LSE:SBTX)
Historical Stock Chart
From May 2023 to May 2024